Clinical Trial Detail

NCT ID NCT02043587
Title Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Diego
Indications

non-Hodgkin lymphoma

acute lymphoblastic leukemia

Therapies

Rituximab

Pegaspargase

Methotrexate

Cytarabine

Leucovorin

Cyclophosphamide

Dasatinib

Daunorubicin

Vincristine Sulfate

Etoposide

Age Groups: adult

No variant requirements are available.